Zlotorzynska Maria, Spaulding Anne C, Messina Lauren C, Coker Daniella, Ward Kevin, Easley Kirk, Baillargeon Jacques, Mink Pamela J, Simard Edgar P
Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
University of Texas Medical Branch, Galveston, Texas, USA.
BMJ Open. 2016 Apr 11;6(4):e009778. doi: 10.1136/bmjopen-2015-009778.
Non-AIDS-defining cancers (NADCs) have emerged as significant contributors to cancer mortality and morbidity among persons living with HIV (PLWH). Because NADCs are also associated with many social and behavioural risk factors that underlie HIV, determining the extent to which each of these factors contributes to NADC risk is difficult. We examined cancer incidence and mortality among persons with a history of incarceration, because distributions of other cancer risk factors are likely similar between prisoners living with HIV and non-infected prisoners.
Registry-based retrospective cohort study.
Cohort of 22,422 persons incarcerated in Georgia, USA, prisons on 30 June 1991, and still alive in 1998.
Cancer incidence and mortality were assessed between 1998 and 2009, using cancer and death registry data matched to prison administrative records. Age, race and sex-adjusted standardised mortality and incidence ratios, relative to the general population, were calculated for AIDS-defining cancers, viral-associated NADCs and non-infection-associated NADCs, stratified by HIV status.
There were no significant differences in cancer mortality relative to the general population in the cohort, regardless of HIV status. In contrast, cancer incidence was elevated among the PLWH. Furthermore, incidence of viral-associated NADCs was significantly higher among PLWH versus those without HIV infection (standardised incidence ratio=6.1, 95% CI 3.0 to 11.7, p<0.001).
Among PLWH with a history of incarceration, cancer incidence was elevated relative to the general population, likely related to increased prevalence of oncogenic viral co-infections. Cancer prevention and screening programmes within prisons may help to reduce the cancer burden in this high-risk population.
非艾滋病定义性癌症(NADCs)已成为导致HIV感染者(PLWH)癌症死亡率和发病率的重要因素。由于NADCs还与许多构成HIV基础的社会和行为风险因素相关,因此很难确定这些因素中每个因素对NADC风险的贡献程度。我们研究了有监禁史者的癌症发病率和死亡率,因为感染HIV的囚犯和未感染HIV的囚犯之间其他癌症风险因素的分布可能相似。
基于登记处的回顾性队列研究。
1991年6月30日被关押在美国佐治亚州监狱且在1998年仍存活的22422人队列。
利用与监狱行政记录匹配的癌症和死亡登记数据,评估1998年至2009年期间的癌症发病率和死亡率。针对艾滋病定义性癌症、病毒相关的NADCs和非感染相关的NADCs,按HIV状态分层,计算相对于一般人群的年龄、种族和性别调整后的标准化死亡率和发病率比值。
无论HIV状态如何,该队列中相对于一般人群的癌症死亡率均无显著差异。相比之下,PLWH中的癌症发病率有所升高。此外,PLWH中病毒相关的NADCs发病率显著高于未感染HIV者(标准化发病率比值=6.1,95%CI 3.0至11.7,p<0.001)。
在有监禁史的PLWH中,癌症发病率相对于一般人群有所升高,这可能与致癌病毒合并感染的患病率增加有关。监狱内的癌症预防和筛查项目可能有助于减轻这一高危人群的癌症负担。